UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000013224 |
|---|---|
| Receipt number | R000015433 |
| Scientific Title | A Phase II Study of Carboplatin plus weekly nab-Paclitaxel in combination with Bevacizumab in chemo-naive patients with stage IIIB and IV non-squamous, non-small cell lung cancer |
| Date of disclosure of the study information | 2014/02/22 |
| Last modified on | 2017/12/31 19:41:42 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/02/22 12:47:22 | ||
| 2 | Update | 2014/02/24 09:37:32 | Public title Acronym |
|
| 3 | Update | 2014/02/24 09:39:04 | Narrative objectives1 |
|
| 4 | Update | 2014/02/24 09:54:55 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 5 | Update | 2014/02/24 09:58:52 | Category of Funding Organization Tel1 Email1 |
|
| 6 | Update | 2014/02/24 15:55:28 | UMIN ID1 |
|
| 7 | Update | 2014/04/01 14:37:48 | Public title Acronym |
|
| 8 | Update | 2014/05/07 23:28:36 | Interventions/Control_1 Interventions/Control_1 |
|
| 9 | Update | 2014/08/25 15:01:18 | Last follow-up date |
|
| 10 | Update | 2017/12/31 19:34:54 | Name of primary person or sponsor Organization |
|
| 11 | Update | 2017/12/31 19:41:42 | Recruitment status Publication of results URL related to results and publications Results |
